Saturday, 24 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Junshi Biosciences’ TAB009/JS009 and JS110 Advance in Cancer Trials
February 11, 2025
Company
Illumina Opens First China Manufacturing Base for Gene Sequencers
February 11, 2025
Company
Drug
Junshi Biosciences Gets NMPA Go-Ahead for TAB009/JS009 Cancer Study
February 11, 2025
Company
Illumina Opens First China Manufacturing Base for Gene Sequencers
February 11, 2025
Company
Novartis to Spin Off Sandoz, Focus on Innovative Drugs
February 11, 2025
Company
Drug
Clover Biopharmaceuticals’ SCB-2019 Vaccine Proves Effective in Teenagers
February 11, 2025
Company
CStone Pharmaceuticals’ H1 2022 Revenue Jumps 229% on Drug Sales Growth
February 11, 2025
Company
Innovent Biologics’ H1 2022 Revenue Rises 15.3% on Drug Sales Growth
February 11, 2025
Company
Akeso Biopharma’s H1 2022 Revenue Rises 26.8% on Penpulimab Sales
February 12, 2025
Company
Drug
Alpha Biopharma Completes EVEREST Trial for Zorifertinib in EGFR+ NSCLC with CNS Metastases
February 12, 2025
Company
Deals
eTheRNA Raises EUR 39M in Series B2 to Expand mRNA Services and Leadership
February 12, 2025
Company
Drug
Sorrento Therapeutics’ Abivertinib Shows Positive Long-Term Data in NSCLC Trial
February 12, 2025
1
2
3
4
5
6
…
21
22
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
